1264 related articles for article (PubMed ID: 27959767)
1. Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes.
Ference BA; Robinson JG; Brook RD; Catapano AL; Chapman MJ; Neff DR; Voros S; Giugliano RP; Davey Smith G; Fazio S; Sabatine MS
N Engl J Med; 2016 Dec; 375(22):2144-2153. PubMed ID: 27959767
[TBL] [Abstract][Full Text] [Related]
2. Mendelian Randomization Study of
Ference BA; Ray KK; Catapano AL; Ference TB; Burgess S; Neff DR; Oliver-Williams C; Wood AM; Butterworth AS; Di Angelantonio E; Danesh J; Kastelein JJP; Nicholls SJ
N Engl J Med; 2019 Mar; 380(11):1033-1042. PubMed ID: 30865797
[TBL] [Abstract][Full Text] [Related]
3. Association Between Low-Density Lipoprotein Cholesterol-Lowering Genetic Variants and Risk of Type 2 Diabetes: A Meta-analysis.
Lotta LA; Sharp SJ; Burgess S; Perry JRB; Stewart ID; Willems SM; Luan J; Ardanaz E; Arriola L; Balkau B; Boeing H; Deloukas P; Forouhi NG; Franks PW; Grioni S; Kaaks R; Key TJ; Navarro C; Nilsson PM; Overvad K; Palli D; Panico S; Quirós JR; Riboli E; Rolandsson O; Sacerdote C; Salamanca EC; Slimani N; Spijkerman AM; Tjonneland A; Tumino R; van der A DL; van der Schouw YT; McCarthy MI; Barroso I; O'Rahilly S; Savage DB; Sattar N; Langenberg C; Scott RA; Wareham NJ
JAMA; 2016 Oct; 316(13):1383-1391. PubMed ID: 27701660
[TBL] [Abstract][Full Text] [Related]
4. Low LDL cholesterol,
Benn M; Nordestgaard BG; Frikke-Schmidt R; Tybjærg-Hansen A
BMJ; 2017 Apr; 357():j1648. PubMed ID: 28438747
[No Abstract] [Full Text] [Related]
5. Association of Genetically Enhanced Lipoprotein Lipase-Mediated Lipolysis and Low-Density Lipoprotein Cholesterol-Lowering Alleles With Risk of Coronary Disease and Type 2 Diabetes.
Lotta LA; Stewart ID; Sharp SJ; Day FR; Burgess S; Luan J; Bowker N; Cai L; Li C; Wittemans LBL; Kerrison ND; Khaw KT; McCarthy MI; O'Rahilly S; Scott RA; Savage DB; Perry JRB; Langenberg C; Wareham NJ
JAMA Cardiol; 2018 Oct; 3(10):957-966. PubMed ID: 30326043
[TBL] [Abstract][Full Text] [Related]
6. Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk.
Ference BA; Kastelein JJP; Ginsberg HN; Chapman MJ; Nicholls SJ; Ray KK; Packard CJ; Laufs U; Brook RD; Oliver-Williams C; Butterworth AS; Danesh J; Smith GD; Catapano AL; Sabatine MS
JAMA; 2017 Sep; 318(10):947-956. PubMed ID: 28846118
[TBL] [Abstract][Full Text] [Related]
7. Genetic Assessment of Potential Long-Term On-Target Side Effects of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibitors.
Nelson CP; Lai FY; Nath M; Ye S; Webb TR; Schunkert H; Samani NJ
Circ Genom Precis Med; 2019 Jan; 12(1):e002196. PubMed ID: 30645167
[TBL] [Abstract][Full Text] [Related]
8. Effect of naturally random allocation to lower low-density lipoprotein cholesterol on the risk of coronary heart disease mediated by polymorphisms in NPC1L1, HMGCR, or both: a 2 × 2 factorial Mendelian randomization study.
Ference BA; Majeed F; Penumetcha R; Flack JM; Brook RD
J Am Coll Cardiol; 2015 Apr; 65(15):1552-61. PubMed ID: 25770315
[TBL] [Abstract][Full Text] [Related]
9. Association Between Genetically Proxied Inhibition of HMG-CoA Reductase and Epithelial Ovarian Cancer.
Yarmolinsky J; Bull CJ; Vincent EE; Robinson J; Walther A; Smith GD; Lewis SJ; Relton CL; Martin RM
JAMA; 2020 Feb; 323(7):646-655. PubMed ID: 32068819
[TBL] [Abstract][Full Text] [Related]
10. Using genetic variants to evaluate the causal effect of cholesterol lowering on head and neck cancer risk: A Mendelian randomization study.
Gormley M; Yarmolinsky J; Dudding T; Burrows K; Martin RM; Thomas S; Tyrrell J; Brennan P; Pring M; Boccia S; Olshan AF; Diergaarde B; Hung RJ; Liu G; Legge D; Tajara EH; Severino P; Lacko M; Ness AR; Davey Smith G; Vincent EE; Richmond RC
PLoS Genet; 2021 Apr; 17(4):e1009525. PubMed ID: 33886544
[TBL] [Abstract][Full Text] [Related]
11. Differential associations of statin treatment and polymorphism in genes coding for HMGCR and PCSK9 to risk for insomnia.
Alsehli AM; Rukh G; Clemensson LE; Ciuculete DM; Tan X; Al-Sabri MH; Williams MJ; Benedict C; Schiöth HB
Front Biosci (Landmark Ed); 2021 Dec; 26(12):1453-1463. PubMed ID: 34994160
[TBL] [Abstract][Full Text] [Related]
12. PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study.
Schmidt AF; Swerdlow DI; Holmes MV; Patel RS; Fairhurst-Hunter Z; Lyall DM; Hartwig FP; Horta BL; Hyppönen E; Power C; Moldovan M; van Iperen E; Hovingh GK; Demuth I; Norman K; Steinhagen-Thiessen E; Demuth J; Bertram L; Liu T; Coassin S; Willeit J; Kiechl S; Willeit K; Mason D; Wright J; Morris R; Wanamethee G; Whincup P; Ben-Shlomo Y; McLachlan S; Price JF; Kivimaki M; Welch C; Sanchez-Galvez A; Marques-Vidal P; Nicolaides A; Panayiotou AG; Onland-Moret NC; van der Schouw YT; Matullo G; Fiorito G; Guarrera S; Sacerdote C; Wareham NJ; Langenberg C; Scott R; Luan J; Bobak M; Malyutina S; Pająk A; Kubinova R; Tamosiunas A; Pikhart H; Husemoen LL; Grarup N; Pedersen O; Hansen T; Linneberg A; Simonsen KS; Cooper J; Humphries SE; Brilliant M; Kitchner T; Hakonarson H; Carrell DS; McCarty CA; Kirchner HL; Larson EB; Crosslin DR; de Andrade M; Roden DM; Denny JC; Carty C; Hancock S; Attia J; Holliday E; O'Donnell M; Yusuf S; Chong M; Pare G; van der Harst P; Said MA; Eppinga RN; Verweij N; Snieder H; ; Christen T; Mook-Kanamori DO; Gustafsson S; Lind L; Ingelsson E; Pazoki R; Franco O; Hofman A; Uitterlinden A; Dehghan A; Teumer A; Baumeister S; Dörr M; Lerch MM; Völker U; Völzke H; Ward J; Pell JP; Smith DJ; Meade T; Maitland-van der Zee AH; Baranova EV; Young R; Ford I; Campbell A; Padmanabhan S; Bots ML; Grobbee DE; Froguel P; Thuillier D; Balkau B; Bonnefond A; Cariou B; Smart M; Bao Y; Kumari M; Mahajan A; Ridker PM; Chasman DI; Reiner AP; Lange LA; Ritchie MD; Asselbergs FW; Casas JP; Keating BJ; Preiss D; Hingorani AD; ; Sattar N
Lancet Diabetes Endocrinol; 2017 Feb; 5(2):97-105. PubMed ID: 27908689
[TBL] [Abstract][Full Text] [Related]
13. Assessing the Impact of PCSK9 and HMGCR Inhibition on Liver Function: Drug-Target Mendelian Randomization Analyses in Four Ancestries.
Rosoff DB; Bell AS; Wagner J; Mavromatis LA; Hamandi A; Park L; Jung J; Lohoff FW
Cell Mol Gastroenterol Hepatol; 2024; 17(1):29-40. PubMed ID: 37703945
[TBL] [Abstract][Full Text] [Related]
14. Causal relationship between PCSK9 inhibitor and primary glomerular disease: a drug target Mendelian randomization study.
Duan H; Shi Y; Zhang Q; Shi X; Zhang Y; Liu J; Zhang Y
Front Endocrinol (Lausanne); 2024; 15():1335489. PubMed ID: 38510702
[TBL] [Abstract][Full Text] [Related]
15. Low LDL Cholesterol by PCSK9 Variation Reduces Cardiovascular Mortality.
Benn M; Tybjærg-Hansen A; Nordestgaard BG
J Am Coll Cardiol; 2019 Jun; 73(24):3102-3114. PubMed ID: 31221259
[TBL] [Abstract][Full Text] [Related]
16. Genetics: HMGCR and PCSK9 variants and cardiovascular risk.
Lim GB
Nat Rev Cardiol; 2017 Feb; 14(2):66. PubMed ID: 27974810
[No Abstract] [Full Text] [Related]
17.
Kent ST; Rosenson RS; Avery CL; Chen YI; Correa A; Cummings SR; Cupples LA; Cushman M; Evans DS; Gudnason V; Harris TB; Howard G; Irvin MR; Judd SE; Jukema JW; Lange L; Levitan EB; Li X; Liu Y; Post WS; Postmus I; Psaty BM; Rotter JI; Safford MM; Sitlani CM; Smith AV; Stewart JD; Trompet S; Sun F; Vasan RS; Woolley JM; Whitsel EA; Wiggins KL; Wilson JG; Muntner P
Circ Cardiovasc Genet; 2017 Aug; 10(4):e001632. PubMed ID: 28768753
[TBL] [Abstract][Full Text] [Related]
18. Genotype-driven NPC1L1 and PCSK9 inhibition and reduced risk of periodontitis.
Baumeister SE; Holtfreter B; Reckelkamm SL; Kocher T; Alayash Z; Ehmke B; Baurecht H; Nolde M
J Clin Periodontol; 2023 Jan; 50(1):114-120. PubMed ID: 36054135
[TBL] [Abstract][Full Text] [Related]
19. PCSK9 Variants, Low-Density Lipoprotein Cholesterol, and Neurocognitive Impairment: Reasons for Geographic and Racial Differences in Stroke Study (REGARDS).
Mefford MT; Rosenson RS; Cushman M; Farkouh ME; McClure LA; Wadley VG; Irvin MR; Bittner V; Safford MM; Somaratne R; Monda KL; Muntner P; Levitan EB
Circulation; 2018 Mar; 137(12):1260-1269. PubMed ID: 29146683
[TBL] [Abstract][Full Text] [Related]
20. Lipid lowering and Alzheimer disease risk: A mendelian randomization study.
Williams DM; Finan C; Schmidt AF; Burgess S; Hingorani AD
Ann Neurol; 2020 Jan; 87(1):30-39. PubMed ID: 31714636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
